Company intelligence / Profile preview

Panakes Partners

Milan, Lombardy, Italypanakes.it ↗

Ownership: Private
Development stage: Other

Overview

Panakes Partners does not develop its own clinical programs but has invested in over 28 life sciences and medtech companies across Europe and Israel. Its portfolio companies have collectively brought five innovative medical products to market and have ten more in active clinical trials. The firm’s funds support the growth of entrepreneurial healthcare companies developing new therapies, vaccines, diagnostics, and devices. The Purple Fund focuses on biotech/medtech investments globally with a target size of €180 million as of 2021.

Industry: Investors

Partnerships

CDP Venture Capital SGR – Fondo Nazionale InnovazioneEuropean Investment FundFountain Healthcare PartnersFoundation for Technological Innovation (FIT)

Beyond the preview

Go deeper on Panakes Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panakes Partners.

Explore the full profile